Axsome Therapeutics Inc (AXSM)
Cost of Revenue
$13.56M
Quarterly · Period ending: · USD
AXSM Cost of Revenue
Latest reported$13.56Mperiod ending
Latest reported$13.56Mperiod ending
AXSM Quarterly Cost of Revenue ($0.00 → $13.56M)
Quarterly cost of revenue
High-resolution chart · PNG
AXSM cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 13,564,000 | |
| 14,725,000 | |
| 12,329,000 | |
| 11,912,000 | |
| 13,448,000 | |
| 9,789,000 | |
| 10,514,000 | |
| 8,437,000 | |
| 8,055,000 | |
| 6,297,000 | |
| 7,378,000 | |
| 6,532,000 | |
| 4,599,000 | |
| 7,556,000 | |
| 2,290,928 | |
| 1,924,000 | |
| 983,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |